• A federal panel has recommended altering a long-standing vaccine policy for newborns. An advisory panel appointed by the Health and Human Services Secretary voted 8-3 to change a 30-year-old policy. The recommendation is to delay the Hepatitis B vaccine from being administered within 24 hours of birth to when an infant is two months old.
• The new recommendation has received support from the administration. Following the advisory panel's vote, President Trump voiced his support for the proposed change to the immunization schedule. This aligns the administration with the panel's decision to delay the Hepatitis B shot.
• Officials cite safety concerns to justify shifts in vaccine approval processes. In a related development, a memo from the head of the FDA's biologic center, Dr. Vinay Prasad, reportedly justified altering the approval process for updated vaccines. The memo cited a finding that at least 10 children died from the COVID-19 vaccine, and an HHS official stated the data would eventually be released.
How it may affect me
As a U.S. reader:
• Parents of newborns may face a new immunization schedule that delays the Hepatitis B shot from birth until two months, changing a 30-year standard practice.
• A cited model suggests the policy change could result in 1,400 additional chronic Hepatitis B infections in infants annually due to potential flaws in maternal testing.
• Disagreement between federal officials and major medical groups, such as the American Academy of Pediatrics, may create confusion for parents regarding their newborns’ vaccination decisions.
• Changes to the FDA's approval process for updated vaccines, citing unreleased safety data, could affect how future vaccines are reviewed and become available to the public.
